Congress Symposia

Age is Not a Barrier: The Older Patient with Comorbidities

Choosing CAR T with Curative Intent

Overview

Speakers:
Dr. Mary Ann Anderson
14.06.2025
Duration: 20 mins 41 secs

This is a recording from a segment of Kite’s global symposium at EHA 2025 titled “Doctor, what is my best chance of a cure? A case-based approach to the evolving landscape of R/R lymphomas.” In this portion of the symposium, Dr. Anderson presents a case study and uses real-world evidence to discuss the current best-practices and role of CAR T in elderly patients with co-morbidities.

Click here to evaluate this content

From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma – Part 1

From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma – Part 1

Overview

Speakers:
Dr. Amaris Balitsky
Dr. Christopher Lemieux
Dr. Mona Shafey
22.05.2025
Duration: 7 mins 46 secs

These are recordings of Kite’s symposium at CTTC 2025 entitled “From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma.” In part 1, Dr. Balitsky introduces the session and discusses the evolving role of CAR T cell therapy in 2L for R/R LBCL. In Part 2, Dr. Lemieux presents a series of patient cases to highlight the role of CAR T in diverse patient populations. In part 3, through a patient case, Dr. Shafey shares best practices for managing rapidly progressing DLBCL and discusses strategies for CAR T capacity planning.

Click here to evaluate this content

From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma – Part 2

From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma – Part 2

Overview

Speakers:
Dr. Amaris Balitsky
Dr. Christopher Lemieux
Dr. Mona Shafey
22.05.2025
Duration: 28 mins 59 secs

These are recordings of Kite’s symposia at CTTC 2025 entitled “From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma.” In part 1, Dr. Balitsky introduces the session and discusses the evolving role of CAR T cell therapy in 2L for R/R LBCL. In Part 2, Dr. Lemieux presents a series of patient cases to highlight the role of CAR T in diverse patient populations. In part 3, through a patient case, Dr. Shafey shares best practices for managing rapidly progressing DLBCL and discusses strategies for CAR T capacity planning.  

Click here to evaluate this content

From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma – Part 3

From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma – Part 3

Overview

Speakers:
Dr. Amaris Balitsky
Dr. Christopher Lemieux
Dr. Mona Shafey
22.05.2025
Duration: 15 mins 03 secs

These are recordings of Kite’s symposia at CTTC 2025 entitled “From Promise to Practice: Case-Based Discussion on Standard of Care Second-line (2L) CAR T Therapy for Aggressive Lymphoma.” In part 1, Dr. Balitsky introduces the session and discusses the evolving role of CAR T cell therapy in 2L for R/R LBCL. In Part 2, Dr. Lemieux presents a series of patient cases to highlight the role of CAR T in diverse patient populations. In part 3, through a patient case, Dr. Shafey shares best practices for managing rapidly progressing DLBCL and discusses strategies for CAR T capacity planning.

Click here to evaluate this content

The Evolving CAR T Journey for Patients with Aggressive Lymphoma and the Critical Role of Nurses—A Canadian Experience – Part 1

The Role of Nurses in a Patient’s Path to CAR T Therapy and Post Treatment Care with Aggressive Lymphoma - Part 1

Overview

Speakers:
Linda Hamelin
Julie Campeau
Josh Smith
Melissa Vicencio
31.10.2025
Duration: 14 mins 35 secs

These are recordings of Kite’s symposium at CANO 2025 entitled “The Evolving CAR T Journey for Patients with Aggressive Lymphoma and the Critical Role of Nurses—A Canadian Experience.” In part 1, Nurse Practitioner, Linda Hamelin provides an overview of the current CAR T journey and 2L LBCL treatment landscape in Canada. In part 2, a panel discussion led by RN Josh Smith walks through a patient case with scenario-based modifications, highlighting the critical role of nurses prior to CAR T treatment. RN Julie Campeau also shares insights on the referral process for CAR T. In part 3, a panel discussion led by RN Melissa Vicencio discusses the critical role of nurses during CAR T infusion and post-infusion. The symposium concludes with a panel discussion where nurses share insights and experiences with the evolving CAR T models at their respective Canadian centers.

Click here to evaluate this content

The Evolving CAR T Journey for Patients with Aggressive Lymphoma and the Critical Role of Nurses—A Canadian Experience – Part 2

The Role of Nurses in a Patient’s Path to CAR T Therapy and Post Treatment Care with Aggressive Lymphoma - Part 2

Overview

Speakers:
Linda Hamelin
Julie Campeau
Josh Smith
Melissa Vicencio
31.10.2025
Duration: 8 mins 06 secs

These are recordings of Kite’s symposium at CANO 2025 entitled “The Evolving CAR T Journey for Patients with Aggressive Lymphoma and the Critical Role of Nurses—A Canadian Experience.” In part 1, Nurse Practitioner, Linda Hamelin provides an overview of the current CAR T journey and 2L LBCL treatment landscape in Canada. In part 2, a panel discussion led by RN Josh Smith walks through a patient case with scenario-based modifications, highlighting the critical role of nurses prior to CAR T treatment. RN Julie Campeau also shares insights on the referral process for CAR T. In part 3, a panel discussion led by RN Melissa Vicencio discusses the critical role of nurses during CAR T infusion and post-infusion. The symposium concludes with a panel discussion where nurses share insights and experiences with the evolving CAR T models at their respective Canadian centers.

Click here to evaluate this content

The Evolving CAR T Journey for Patients with Aggressive Lymphoma and the Critical Role of Nurses—A Canadian Experience – Part 3

The Role of Nurses in a Patient’s Path to CAR T Therapy and Post Treatment Care with Aggressive Lymphoma - Part 3

Overview

Speakers:
Linda Hamelin
Julie Campeau
Josh Smith
Melissa Vicencio
31.10.2025
Duration: 29 mins 11 secs

These are recordings of Kite’s symposium at CANO 2025 entitled “The Evolving CAR T Journey for Patients with Aggressive Lymphoma and the Critical Role of Nurses—A Canadian Experience.” In part 1, Nurse Practitioner, Linda Hamelin provides an overview of the current CAR T journey and 2L LBCL treatment landscape in Canada. In part 2, a panel discussion led by RN Josh Smith walks through a patient case with scenario-based modifications, highlighting the critical role of nurses prior to CAR T treatment. RN Julie Campeau also shares insights on the referral process for CAR T. In part 3, a panel discussion led by RN Melissa Vicencio discusses the critical role of nurses during CAR T infusion and post-infusion. The symposium concludes with a panel discussion where nurses share insights and experiences with the evolving CAR T models at their respective Canadian centers.

Click here to evaluate this content

Understanding the Role of CAR T in R/R Adult ALL and Exploring CAR T Treatment Approaches in R/R Adult ALL

Understanding the Role of CAR T in R/R Adult ALL and Exploring CAR T Treatment Approaches in R/R Adult ALL

Overview

Speakers:
Dr. Bijal Shah
Dr. Florence Rabian
08.06.2023
Duration: 27 mins 21 secs

As part of Kite’s symposia at EHA 2023 entitled “Managing R/R Adult ALL in the CAR T Era”, Dr. Shah and Dr. Rabian discuss CAR T treatment approaches in R/R adult ALL, including clinical trial and real-world data updates, as well as present real patient cases.

Click here to evaluate this content